Vireo is in early access and completely free until 1 August 2026. Everyone who signs up before then keeps the founding-member price permanently: €3/month (normally €5).
Vireo
/

Joakim Tedroff — Management

Roles

IRLAB Therapeutics AB Stockholm
Management
17.07.2025 – 01.07.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
01.07.2026IRLAB Therapeutics AB Stockholm
New shares (subscription)
via Borkholmen Invest AB
4,016,742SEK 1.20
SEK 4,820,090.40
↗
26.06.2026✎IRLAB Therapeutics AB Stockholm
New shares (subscription)
555,842SEK 1.20
SEK 667,010.40
↗
28.11.2025IRLAB Therapeutics AB Stockholm
Bought — open marketAcquisition
250,000SEK 2.00
SEK 500,000.00
↗
20.11.2025IRLAB Therapeutics AB Stockholm
Bought — open marketAcquisition
70,000SEK 2.00
SEK 140,000.00
↗
12.11.2025IRLAB Therapeutics AB Stockholm
Bought — open marketAcquisition
50,000SEK 2.40
SEK 120,000.00
↗
18.07.2025IRLAB Therapeutics AB Stockholm
New shares (subscription)
357,327SEK 3.50
SEK 1,250,644.50
↗
17.07.2025IRLAB Therapeutics AB Stockholm
New shares (subscription)
116,196SEK 3.50
SEK 406,686.00
↗